Specialty Overview

Best Hospitals for Bile Duct Cancer Treatment in India

90 surgical oncology hospitals in our India network are listed, across 5 cities (Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai), accredited by JCI, NABH, ISO, NABL, with 51,822 beds combined.

90
Hospitals Listed
5
Cities
4.5
Avg. Rating
5
Accreditation Types
The Short Answer

This page lists the surgical oncology hospitals in our directory offering Bile Duct Cancer Treatment in India, including Nanavati Super Specialty Hospital, Apollo Hospitals, Medanta - The Medicity, Artemis Hospital and others. Hospitals are listed across Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Each listing links through to the hospital's full profile page.

Documented costs range from $1,800 to $9,000 depending on the exact diagnosis, based on our published cost guides.

Ask us about bile duct cancer treatment in India

Share a few details and our care coordination team will get back to you with next steps.

Compare 90 accredited hospitals for Surgical Oncology in India

Starting from$1,000

🇮🇳 Nanavati Super Specialty Hospital

Mumbai, India 5 (12 reviews) 350 beds
Why consider this hospital?
5/5 rating from 12 reviewsAccredited by JCI, NABH350 beds
Specialties & Accreditation
OncologyCardiac SurgeryNeurosciencesTransplantBariatrics
Accredited by JCI, NABH

Patients considering bile duct cancer treatment can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

5/5
Rating
1950
Established
350
Beds
Mumbai, India
Location
Apollo Hospitals
Starting from$1,000

🇮🇳 Apollo Hospitals

New Delhi, India 4.9 (1240 reviews) 1,000 beds
Why consider this hospital?
4.9/5 rating from 1240 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering bile duct cancer treatment can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

4.9/5
Rating
1983
Established
1,000
Beds
New Delhi, India
Location
Medanta - The Medicity
Starting from$1,000

🇮🇳 Medanta - The Medicity

Gurgaon, India 4.9 (2150 reviews) 1,600 beds
Why consider this hospital?
4.9/5 rating from 2150 reviewsAccredited by JCI, NABH1,600 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering bile duct cancer treatment can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

4.9/5
Rating
2009
Established
1,600
Beds
Gurgaon, India
Location
Artemis Hospital
Starting from$1,000

🇮🇳 Artemis Hospital

Gurgaon, India 4.9 (64 reviews) 750 beds
Why consider this hospital?
4.9/5 rating from 64 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgerySpine SurgeryBariatric Surgery
Accredited by JCI, NABH

Patients considering bile duct cancer treatment can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

4.9/5
Rating
2007
Established
750
Beds
Gurgaon, India
Location
Fortis Memorial Research Institute
Starting from$1,000

🇮🇳 Fortis Memorial Research Institute

Gurgaon, India 4.8 (1100 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1100 reviewsAccredited by JCI, NABH1,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering bile duct cancer treatment can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

4.8/5
Rating
1996
Established
1,000
Beds
Gurgaon, India
Location
Kokilaben Dhirubhai Ambani Hospital
Starting from$1,000

🇮🇳 Kokilaben Dhirubhai Ambani Hospital

Mumbai, India 4.8 (1800 reviews) 750 beds
Why consider this hospital?
4.8/5 rating from 1800 reviewsAccredited by JCI, NABH750 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyMedical OncologyBreast SurgeryBariatric SurgeryVascular Surgery
Accredited by JCI, NABH

Patients considering bile duct cancer treatment can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

4.8/5
Rating
2009
Established
750
Beds
Mumbai, India
Location
Tata Memorial Hospital
Starting from$1,000

🇮🇳 Tata Memorial Hospital

Mumbai, India 4.8 (2500 reviews) 629 beds
Why consider this hospital?
4.8/5 rating from 2500 reviewsAccredited by NABH629 beds
Specialties & Accreditation
OncologyCancer Center
Accredited by NABH

Patients considering bile duct cancer treatment can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

4.8/5
Rating
1941
Established
629
Beds
Mumbai, India
Location
Max Super Specialty Hospital
Starting from$1,000

🇮🇳 Max Super Specialty Hospital

New Delhi, India 4.8 (1300 reviews) 500 beds
Why consider this hospital?
4.8/5 rating from 1300 reviewsAccredited by JCI, NABH500 beds
Specialties & Accreditation
CardiacLiver Transplant
Accredited by JCI, NABH

Patients considering bile duct cancer treatment can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

4.8/5
Rating
2000
Established
500
Beds
New Delhi, India
Location
Narayana Health
Starting from$1,000

🇮🇳 Narayana Health

Bengaluru, India 4.8 (1750 reviews) 1,000 beds
Why consider this hospital?
4.8/5 rating from 1750 reviewsAccredited by NABH1,000 beds
Specialties & Accreditation
CardiacPediatric SurgeryCancer
Accredited by NABH

Patients considering bile duct cancer treatment can be cared for by Narayana Health's care team in Bengaluru, India, from initial consultation through recovery. Narayana Health, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

4.8/5
Rating
2000
Established
1,000
Beds
Bengaluru, India
Location
Yashoda Hospitals, Hi-Tech City
Starting from$1,000

🇮🇳 Yashoda Hospitals, Hi-Tech City

Hi-Tech City, Hyderabad, India 4.8 (742 reviews) 2,000 beds
Why consider this hospital?
4.8/5 rating from 742 reviewsAccredited by JCI, NABH2,000 beds
Specialties & Accreditation
Cardiac SurgeryCardiologyOncologyNeurologyOrthopedicsOrgan Transplant
Accredited by JCI, NABH

Patients considering bile duct cancer treatment can be cared for by Yashoda Hospitals, Hi-Tech City's care team in Hi-Tech City, Hyderabad, India, from initial consultation through recovery. Yashoda Hospitals, Hi-Tech City, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing bile duct cancer treatment.

4.8/5
Rating
1989
Established
2,000
Beds
Hi-Tech City, Hyderabad, India
Location
Our Methodology

How we selected these hospitals

A hospital appears on this page when Surgical Oncology is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.

What To Look For

How to Select the Best Hospital for Bile Duct Cancer Treatment in India?

Choosing the right hospital for bile duct cancer treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:

International Accreditation

Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.

Specialization

Check that the hospital's listed specialties actually include surgical oncology rather than only general care.

Capacity and Track Record

Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.

Transparent Costs

Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.

Clinical Overview

Understanding Bile Duct Cancer Treatment

Bile duct cancer (cholangiocarcinoma) is a rare but aggressive malignancy arising from the epithelial cells lining the biliary tract, requiring a highly specialized multidisciplinary approach that integrates hepatobiliary surgery, interventional oncology, and precision medicine.

10–21 days (varies by surgical complexity and adjuvant treatment phase)
Hospital Stay
4–8 weeks (longer for major hepatic resection; shorter for palliative stenting or systemic therapy initiation)
Total Stay in Country (Fit-to-Fly)
Curative resection: 25–40% long-term disease-free survival; palliative/systemic therapy disease control rate: 50–65%
Success Rate

Clinical Overview

  • Cholangiocarcinoma (bile duct cancer) originates from cholangiocytes — the epithelial cells lining the intrahepatic, perihilar (Klatskin tumor), or distal extrahepatic bile ducts.
  • It is classified anatomically as intrahepatic (iCCA), perihilar (pCCA), or distal cholangiocarcinoma (dCCA), each with distinct surgical approaches, staging systems, and molecular profiles.
  • The Bismuth-Corlette classification remains the cornerstone for stratifying perihilar tumors (Types I–IV), directly determining resectability and the extent of hepatic resection required.
Full details →

Who is a Candidate?

  • ELIGIBLE FOR SURGICAL RESECTION (Curative Intent):
  • Patients with anatomically resectable intrahepatic, perihilar, or distal bile duct tumors confirmed on MRCP and CECT
  • Adequate future liver remnant (FLR): minimum 25–30% in normal liver, 40% in cirrhotic or post-chemotherapy liver (assessed by volumetric CT)
  • No radiological evidence of distant metastases on PET-CT
  • +31 more

Treatment Options & Approaches

  • SURGICAL APPROACHES (Curative Intent):

Recovery

  • PRE-OPERATIVE / PRE-TREATMENT PHASE (Weeks 1–4 before intervention):

Risks to be aware of

  • Bile duct cancer treatment carries a spectrum of procedure-specific and oncology-related risks that must be contextualized honestly.
  • For major hepatectomy and bile duct excision, the most serious risks include post-hepatectomy liver failure (PHLF) — occurring in up to 8–10% of extended resections — which carries significant mortality if ISGLS Grade C is reached; bile leak (Grade B/C in 5–15% of cases, requiring percutaneous drainage or re-exploration); post-operative biliary stricture at the hepaticojejunostomy anastomosis (long-term risk of 5–10%); intra-abdominal hemorrhage; and septic cholangitis.
Full details →

Why GAF Healthcare

  • GAF Healthcare provides comprehensive non-medical coordination services that begin the moment a patient initiates contact and continue through long-term post-treatment follow-up, regardless of whether the destination is India or the UAE.

Cost Range for Related Procedures

Cancer Surgery$4,000$15,000
Chemotherapy$1,000$4,000
Radiation Therapy$3,500$10,000
Get a personalised estimate with our cost calculator →

Common questions about Bile Duct Cancer Treatment

What is the cost of Bile Duct Cancer Treatment in India vs the UAE?
The total cost of bile duct cancer treatment varies significantly depending on the disease stage, treatment modality, and the patient's specific molecular profile. In India, at JCI- and NABH-accredited hepatobiliary oncology centers, costs typically range from $6,000 to $22,000 USD. This range covers: biliary drainage procedures (ERCP/PTC stenting) at the lower end (~$3,000–$6,000), locoregional therapies such as TACE or Y-90 SIRT ($6,000–$12,000), and major hepatobiliary surgery — extended hepatectomy with bile duct excision or Whipple procedure — at the upper end ($12,000–$22,000). The cost of targeted therapies such as pemigatinib, futibatinib, or ivosidenib, and immunotherapy with durvalumab, are quoted separately as per-cycle drug costs and are variable. In the UAE, at JCI- and DHA-accredited centers in Dubai and Abu Dhabi, equivalent treatment costs range from $15,000 to $50,000 USD — approximately 50–65% higher than India — reflecting premium hospital infrastructure, higher surgical facility fees, and the UAE's overall healthcare cost structure. India offers the same internationally benchmarked oncological expertise (many surgeons are fellowship-trained in Europe or the US) at the lowest cost, making it the preferred destination for patients prioritizing affordability without compromising quality. The UAE is ideal for patients from the GCC region or those prioritizing proximity, luxury amenities, and premium care environments. GAF Healthcare provides fully itemized, no-obligation cost estimates for both destinations before any commitment is made.
How long do I need to stay in the country before I am fit to fly home after Bile Duct Cancer Treatment?
The required in-country stay before you are medically cleared for international travel depends entirely on which treatment you receive. For biliary stenting (ERCP or PTC) performed as a standalone palliative or pre-operative procedure, you will typically be fit to fly within 7–14 days, provided there are no complications such as post-procedural cholangitis or pancreatitis. For locoregional therapies such as TACE (transarterial chemoembolization) or Y-90 radioembolization (TARE/SIRT) for intrahepatic CCA, the minimum safe in-country stay is 2–3 weeks, allowing monitoring for post-embolization syndrome, biloma formation, and liver function stabilization. For chemotherapy initiation (gemcitabine-cisplatin-durvalumab), patients typically stay 2–3 weeks to complete Cycle 1 and monitor for acute toxicities including nephrotoxicity, myelosuppression, and infusion reactions, before returning home to continue treatment locally. For major hepatobiliary surgery — extended hepatectomy with bile duct excision or pancreaticoduodenectomy (Whipple procedure) — the total in-country stay is 6–8 weeks. Hospital stay alone is 14–21 days, followed by 3–4 weeks of post-discharge recovery at nearby accommodation. Medical clearance for a long-haul flight requires: normalization of serum bilirubin, absence of bile leak or active infection, adequate oral nutritional intake, wound healing, and written physician clearance. Long-haul flights for post-surgical oncology patients also require prophylactic low molecular weight heparin (LMWH) due to elevated VTE risk, which your treating team will prescribe. GAF Healthcare's case managers work closely with your treating surgeon to provide an individualized, evidence-based fit-to-fly certification before your departure is planned.
What is the success rate of Bile Duct Cancer Treatment?
Success rates in bile duct cancer (cholangiocarcinoma) treatment are highly stage-dependent and must be understood in the context of the specific treatment received. For surgically resectable disease treated with curative-intent R0 resection, the 5-year overall survival is approximately 25–40% for perihilar CCA and 20–35% for intrahepatic CCA, rising to 40–50% in node-negative, margin-negative cases at high-volume centers. When adjuvant capecitabine is added post-resection (per BILCAP trial), median overall survival improves to approximately 51.1 months versus 36.4 months with surgery alone. For the highly selected group of perihilar CCA patients undergoing orthotopic liver transplantation following the Mayo Clinic neoadjuvant chemoradiation protocol, 5-year survival rates of 65–70% have been reported — the best outcomes in the disease spectrum for this subgroup. For unresectable or metastatic cholangiocarcinoma treated with the current first-line standard — gemcitabine plus cisplatin plus durvalumab (TOPAZ-1 regimen) — the 24-month overall survival rate is approximately 24.9%, with a median overall survival of 12.8 months, representing a meaningful improvement over chemotherapy alone. Patients with FGFR2 fusion-positive disease treated with pemigatinib or futibatinib in the second-line setting achieve objective response rates of approximately 35%, with median progression-free survival of 6–9 months. IDH1-mutant patients on ivosidenib demonstrate disease control rates of approximately 55%. MSI-H patients treated with pembrolizumab may achieve durable remissions exceeding 2 years in approximately 15–20% of cases. It is important to understand that 'success' in CCA management is measured not only by cure rates — which remain modest in advanced disease — but also by quality of life, duration of biliary patency, freedom from cholangitis, and meaningful time with preserved function. The multidisciplinary, molecularly guided approach at GAF Healthcare's partner centers optimizes all these outcomes.
The Cost Landscape

Surgical Oncology Treatment Cost in India, by Diagnosis

Use the cost calculator

From our published, verified cost guides only — each row links through to the full breakdown.

DiagnosisRange, USD
Breast Cancer$1,800–$9,000View breakdown →

Indicative planning estimates only, not a quote — actual pricing depends on your case, hospital choice, and length of stay.

How GAF Healthcare Assists in Choosing the Best Hospital for Bile Duct Cancer Treatment in India

Discover the Top Hospitals for Bile Duct Cancer Treatment in India

This page lists 90 accredited surgical oncology hospitals in India, so you can compare accreditation, specialties and bed capacity in one place.

Support When You Need It Most

Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.

Transparent, All-Inclusive Costs

We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.

Visa, Travel and Stay Coordination

Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.

Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.

Common Questions

Frequently asked questions about bile duct cancer treatment in India

How many surgical oncology hospitals are listed in India?
90 hospitals in our India directory are currently listed for surgical oncology including Bile Duct Cancer Treatment.
How do you choose which hospitals to list?
A hospital appears on this page when Surgical Oncology is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How much does treatment cost in India?
Based on our published, verified cost guides, documented costs range from $1,800 to $9,000 depending on the exact diagnosis. See the "Cost Landscape" table above for a breakdown by diagnosis.
Which cities in India have surgical oncology hospitals listed?
Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Use the city links on this page to view hospitals in a specific city.
Are these hospitals internationally accredited?
Hospitals listed on this page carry accreditations including JCI, NABH, ISO, NABL — see the accreditation badge shown for each hospital below.
Can I get a treatment plan and cost estimate before I travel?
Based on our published, verified cost guides, documented costs range from $1,800 to $9,000 depending on the exact diagnosis. See the "Cost Landscape" table above for a breakdown by diagnosis.
Do you help with visa, travel and accommodation?
Yes. Once you choose a hospital, our team helps arrange the medical visa invitation letter, book accommodation near the hospital, and organise airport pickup and transport to appointments.
What support do I get during and after treatment?
Our medical team reviews your reports and stays in touch throughout your treatment journey — from the first consultation through recovery, including after you return home.
What does the "Featured" label next to a hospital's name mean?
"Featured" reflects editorial prominence on this listing, not a clinical ranking or a claim that it is the "best" hospital.
How do I get matched with the right hospital for bile duct cancer treatment?
Share your medical reports and requirements with the GAF Healthcare team, and our medical coordinators will recommend a suitable hospital from this list based on your case.
Does the listed cost cover everything?
Based on our published, verified cost guides, documented costs range from $1,800 to $9,000 depending on the exact diagnosis. See the "Cost Landscape" table above for a breakdown by diagnosis.
🤔

Still have questions?

Our coordinators are here to answer your questions about bile duct cancer treatment in India.

Next Step

Share your medical reports with us and our team will recommend a hospital and treatment plan for bile duct cancer treatment in India.

Contact us to report an inaccuracy on this page.